Finn Patrick John 4
4 · Twist Bioscience Corp · Filed Jul 27, 2026
Research Summary
AI-generated summary of this filing
Twist Bioscience COO Finn Patrick John Sells 2,238 Shares
What Happened
Finn Patrick John, President and COO of Twist Bioscience (TWST), sold 2,238 shares on July 23, 2026 at $93.89 per share, generating proceeds of approximately $210,133. The reported sale is a disposal (code S) and was reported on a Form 4 filed July 27, 2026.
Key Details
- Transaction date and price: 2026-07-23, 2,238 shares at $93.89 each.
- Total proceeds: ~$210,133.
- Shares owned after transaction: not specified in the provided summary of the filing.
- Footnote: Sale was a "sell to cover" to satisfy tax withholding on RSU vesting (footnote F1). These mandated sales are not discretionary trades by the insider.
- Filing timeliness: Form 4 filed on 2026-07-27; filing appears timely (not marked late).
Context
This was a routine sell-to-cover related to restricted stock unit (RSU) tax withholding rather than a voluntary open-market sale intended to change ownership exposure. Such transactions are common when equity awards vest and generally do not by themselves indicate the insider's view on the company's prospects.
Insider Transaction Report
Form 4
Finn Patrick John
President and COO
Transactions
- Sale
Common Stock
[F1]2026-07-23$93.89/sh−2,238$210,133→ 272,566 total
Footnotes (1)
- [F1]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
Signature
/s/ Kendra Fox, as Attorney-in-Fact for Patrick John Finn|2026-07-27